Detalhe da pesquisa
1.
Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition.
Cell
; 183(3): 786-801.e19, 2020 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33125893
2.
A multiplex UPLC-MS/MS method for the quantification of three PD-L1 checkpoint inhibitors, atezolizumab, avelumab, and durvalumab, in human serum.
J Pharm Biomed Anal
; 243: 116108, 2024 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38522382
3.
ELISA assay for the quantification of ipilimumab in human serum, plasma, milk, and cerebrospinal fluid.
J Pharm Biomed Anal
; 245: 116140, 2024 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38701533
4.
Optimized sample pre-treatment procedure for the simultaneous UPLC-MS/MS quantification of ipilimumab, nivolumab, and pembrolizumab in human serum.
J Chromatogr B Analyt Technol Biomed Life Sci
; 1196: 123215, 2022 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276512
5.
Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLC-MS/MS.
J Pharm Biomed Anal
; 203: 114225, 2021 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34242947
6.
Quantification of anti-SARS-CoV-2 antibodies in human serum with LC-QTOF-MS.
J Pharm Biomed Anal
; 205: 114319, 2021 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416552